<?xml version='1.0' encoding='utf-8'?>
<document id="24305043"><sentence text="Drug interactions between antiretrovirals and new or emerging direct-acting antivirals in HIV/hepatitis C virus coinfection." /><sentence text="We reviewed the pharmacokinetic interactions between direct-acting antivirals against hepatitis C virus (HCV) and antiretroviral agents" /><sentence text="" /><sentence text="Most relevant pharmacokinetic studies involve healthy individuals and refer to the already licensed HCV protease inhibitors, boceprevir and telaprevir"><entity charOffset="125-135" id="DDI-PubMed.24305043.s4.e0" text="boceprevir" /><entity charOffset="140-150" id="DDI-PubMed.24305043.s4.e1" text="telaprevir" /><pair ddi="false" e1="DDI-PubMed.24305043.s4.e0" e2="DDI-PubMed.24305043.s4.e0" /><pair ddi="false" e1="DDI-PubMed.24305043.s4.e0" e2="DDI-PubMed.24305043.s4.e1" /></sentence><sentence text=" Data from a phase II clinical trial question the clinical relevance of the interactions between boceprevir and HIV protease inhibitors"><entity charOffset="97-107" id="DDI-PubMed.24305043.s5.e0" text="boceprevir" /></sentence><sentence text=" The use of a higher dose of telaprevir appears to offset the effect of efavirenz on telaprevir metabolism according to another phase II trial"><entity charOffset="29-39" id="DDI-PubMed.24305043.s6.e0" text="telaprevir" /><entity charOffset="72-81" id="DDI-PubMed.24305043.s6.e1" text="efavirenz" /><entity charOffset="85-95" id="DDI-PubMed.24305043.s6.e2" text="telaprevir" /><pair ddi="false" e1="DDI-PubMed.24305043.s6.e0" e2="DDI-PubMed.24305043.s6.e0" /><pair ddi="false" e1="DDI-PubMed.24305043.s6.e0" e2="DDI-PubMed.24305043.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24305043.s6.e0" e2="DDI-PubMed.24305043.s6.e2" /><pair ddi="false" e1="DDI-PubMed.24305043.s6.e1" e2="DDI-PubMed.24305043.s6.e1" /><pair ddi="false" e1="DDI-PubMed.24305043.s6.e1" e2="DDI-PubMed.24305043.s6.e2" /></sentence><sentence text=" Boceprevir and particularly telaprevir substantially increase the exposure to maraviroc, similarly to other potent CYP3A4 inhibitors"><entity charOffset="1-11" id="DDI-PubMed.24305043.s7.e0" text="Boceprevir" /><entity charOffset="29-39" id="DDI-PubMed.24305043.s7.e1" text="telaprevir" /><entity charOffset="79-88" id="DDI-PubMed.24305043.s7.e2" text="maraviroc" /><pair ddi="false" e1="DDI-PubMed.24305043.s7.e0" e2="DDI-PubMed.24305043.s7.e0" /><pair ddi="false" e1="DDI-PubMed.24305043.s7.e0" e2="DDI-PubMed.24305043.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24305043.s7.e0" e2="DDI-PubMed.24305043.s7.e2" /><pair ddi="false" e1="DDI-PubMed.24305043.s7.e1" e2="DDI-PubMed.24305043.s7.e1" /><pair ddi="false" e1="DDI-PubMed.24305043.s7.e1" e2="DDI-PubMed.24305043.s7.e2" /></sentence><sentence text=" Different dosages of faldaprevir and daclatasvir have been recommended to be used in combination with a boosted HIV protease inhibitor vs"><entity charOffset="22-33" id="DDI-PubMed.24305043.s8.e0" text="faldaprevir" /><entity charOffset="38-49" id="DDI-PubMed.24305043.s8.e1" text="daclatasvir" /><pair ddi="false" e1="DDI-PubMed.24305043.s8.e0" e2="DDI-PubMed.24305043.s8.e0" /><pair ddi="false" e1="DDI-PubMed.24305043.s8.e0" e2="DDI-PubMed.24305043.s8.e1" /></sentence><sentence text=" an efavirenz-based antiretroviral regimen"><entity charOffset="4-13" id="DDI-PubMed.24305043.s9.e0" text="efavirenz" /></sentence><sentence text=" HIV protease inhibitors appear to substantially increase the exposure to simeprevir" /><sentence text=" The interactions between sofosbuvir and most antiretroviral agents do not appear to be of clinical relevance or to require dosage modifications"><entity charOffset="26-36" id="DDI-PubMed.24305043.s11.e0" text="sofosbuvir" /></sentence><sentence text="" /><sentence text="The drug-drug interaction studies for HCV direct-acting antivirals and antiretrovirals are important in determining the appropriate drug combinations and dosages" /><sentence text=" The clinical implications of these interactions need further assessment in different categories of patients, including those with cirrhosis" /><sentence text="" /></document>